Evidence map›Paper›PMID 42482463›Full record

ArticleVirulence2026

Multifaceted effects of

Jie Yu, Jinying Wang, Yan Yang, Lang Sun, Xinxin Hu, Tongying Nie, Xinyi Yang, Xiukun Wang, Congran Li, Xuefu You

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Virulence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Multifaceted effects ofVirulence · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jie YuBeijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Developments/Department of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Jinying WangBeijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Developments/Department of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Yan YangMedical Research Center, The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, China.
Lang SunBeijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Developments/Department of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Xinxin HuBeijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Developments/Department of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Tongying NieBeijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Developments/Department of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Xinyi YangBeijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Developments/Department of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Xiukun WangBeijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Developments/Department of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Congran LiBeijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Developments/Department of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.ORCID 0000-0002-7505-7525
Xuefu YouBeijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Developments/Department of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bacterial ProteinsGene DeletionPseudomonas aeruginosaAnimalsAnti-Bacterial AgentsCRISPR-Cas SystemsMiceMicrobial Sensitivity TestsO AntigensPhenotypePolymyxinsPseudomonas InfectionsQuorum SensingVirulenceAnti-Bacterial AgentsBacterial ProteinsO antigen, PseudomonasO AntigensPolymyxinsgalU deletionpolymyxin resistancePseudomonas aeruginosaquorum sensingtyrosine metabolismvirulence

Identifiers

PMID42482463
PMCPMC13432885

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.